Novo Nordisk Says Its 'Wegovy In A Pill' Delivers Big: '16.6% Average' Weight Loss, Over 20% For One-Third Of Adults Struggling With Obesity
Marjorie Taylor Greene Goes Stock Shopping Again: Here Are 50+ Stocks The Congresswoman Bought
Trump Planning on Executive Order to Further Cut Medicare Drug Prices - Report
Lilly Benefits as Judge Upholds FDA Removing Zepbound From Shortages List
Vertex Pharma Extends Selloff as Wolfe Downgrades After Q1 Miss
Gilead to Invest About $32B in U.S. Manufacturing Through 2030
S&P 500's Five Most Overbought and Oversold Stocks
SA Analyst Upgrades: TSLA, MSFT, AMD, PLTR, VRTX, ONON, CB
Preview: Natera's Earnings
Price Over Earnings Overview: Regeneron Pharmaceuticals
Novo Nordisk's Wegovy Sales Surge 85% But Compounded Weight Loss Drugs In US Impacts Annual Outlook
Natera's Prospera Heart With DQS Cuts False Positives By Over 37%, Outperforming Dd-cfDNA Percentage Alone, AJT Publication Shows
AstraZeneca And Daiichi Sankyo's ENHERTU Followed By THP Shows Improved Safety Profile Vs. Standard Of Care
Novo Nordisk Cuts 2025 Outlook. But Why Are Its Shares Rising?
AstraZeneca And Daiichi Sankyo's ENHERTU Achieves Significant PCR Gains With Improved Safety Profile In Early HER2 Positive Breast Cancer Patients
Trump wants to impose tariffs on Pharmaceuticals: Pharmaceutical companies are busy stockpiling, and the import volume in the USA surged in March.
① The volume of Pharmaceutical imports in the USA surged in March, as pharmaceutical companies stockpiled products in anticipation of potential tariffs; ② A report released by the US Department of Commerce on Tuesday showed that the total value of Pharmaceutical imports in March exceeded 50 billion USD, equivalent to 20% of the total Pharmaceutical imports for the entire year of 2024.
Tempus AI Raises Revenue Guidance to $1.25B for 2025, Supported by New $200M AstraZeneca Deal
Why Did Vertex Pharmaceuticals Stock Fall On Tuesday?
Eli Lilly Stock Is Sliding Tuesday: What's Going On?
Earnings Call Summary | Krystal Biotech(KRYS.US) Q1 2025 Earnings Conference